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Addiction medicine: an important field for Public Health
The abuse of illegal drugs is one of the greatest challenges that the
world is facing today. Occurring in all countries, from the richest to the
poorest, it is a problem that involves all groups and, increasingly, all
ages, fuelling global crime, corruption and terrorism, generating
unimaginable wealth for the few and limitless harm for the many, cost-
ing millions of lives and threatening the very sustainability of commu-
nities the world over.1
This year marks the one hundredth anniversary of the ratification of
the first international treaty on drug dependence: the Opium
Convention at The Hague.1 However, the world is still haunted by the
continued abuse of drugs. According to the United Nations Office of
Drug Control, estimates of illicit drug use range from 149 to 271 mil-
lion people worldwide and are associated with 200,000 premature
deaths.2 Society has been trying to deal with this problem for over a
hundred years but today the abuse of illegal drugs remains an enor-
mous challenge and there is a frighteningly high social price to pay.3
The problem now seems to be taking on a new dimension with an
increase in the non-medical use of prescription pharmaceuticals, par-
ticularly opioid pain medications. The prevalence of non-medical use
of prescription medications may soon surpass illicit drug use.4 In the
United States, only marijuana surpasses prescription pain medica-
tions as the first substance for initiation of illicit drug use.5
Although illicit drug use is a prevalent and disturbing global prob-
lem, the most widely used drugs are alcohol and tobacco. The harmful
use of alcohol is responsible for 2.5 million deaths annually and is
identified as the third largest risk factor for premature mortality, dis-
ability, and health problems.6 According to the World Health
Organization (WHO) tobacco is used by 1 billion people, 80% living in
low and middle-income countries. Tobacco consumption causes the
death of nearly 6 million people each year, 600,000 of whom are killed
by second-hand passive smoking.7
Family members, friends, co-workers, and community members
from different regions and countries experiencing the visible and dev-
astating social consequences of drug abuse and dependence may con-
clude that there is no solution to addiction and it remains a social or
moral problem.8 Such assumptions dictate that solutions lie in restrict-
ing supply, interdiction, and incarceration of the user. As a social prob-
lem, there is no role for either medical treatment or public health
approaches, such as harm-risk reduction (e.g. needle and syringe
exchange programs). Changes in these perceptions may be hindered
by the stigma attached to drug dependence.9
However, some people may try to seduce us into thinking that drug
addiction is a moral weakness and not a disease, that effective medical
treatment is a fiction, and that the answer to all this is criminalization.
Modern medical research and neuroscience have demonstrated that
this view is seriously flawed, if not simply wrong. In 2000, McLellan
and colleagues argued that drug dependence is a chronic health prob-
lem, sharing characteristics with other chronic diseases such as
hypertension, type 2 diabetes mellitus, and asthma.8 As with these
other health conditions, the influence of heritability in drug depend-
ence has been established, its etiology involves genetic and environ-
mental factors, and the pathophysiology has been determined and
involves changes in brain chemistry and function. The response to
treatment of drug dependence, like for other chronic diseases, is influ-
enced by varying adherence to treatment regimens. Effective treat-
ments for asthma and diabetes exist; so too are there effective treat-
ments for nicotine, alcohol, and opioid dependence. Dietary choices
and exercise impact the outcome of diabetes; lifestyle choices impact
the outcome of treatments for drug dependence. This does not invali-
date the fundamental view that once dependence has developed, sub-
stances hijack the brain, diminishing volitional choice. An individual
diagnosed with addiction needs treatment, and the family and commu-
nity must also be healed of the effects of this illness.10
Public health is a discipline concerned with safeguarding and
improving the physical, mental and social health, and wellbeing of the
community as a whole. Drug dependence IS a community problem.
Effective and culturally appropriate public health campaigns, using
analytical and communicative strategies, are central to reducing the
abuse of legal and illegal drugs and medications, preventing drug
dependence, and increasing acceptance of medical treatment for those
affected. This will play an important and key role in challenging preju-
diced and stigmatized views of this important health issue. This, in
turn, will hopefully increase access to treatment for individuals, fami-
lies and communities.
After 100 years, drug abuse and addiction persist and are a much
larger problem than the opium trade of 1912. A public health approach
is central to addressing a chronic health problem that has been with us
for over a thousand years.
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